$ITOR
Intorio, Corp.

2023 Q1 Form 10-K Financial Statement

#000168316823002642 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2023 2022
Revenue $1.600K $2.100K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.220K $27.55K $22.71K
YoY Change 21.31% 1197.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $670.00 $2.670K $2.670K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $5.220K $27.55K $22.71K
YoY Change 21.32% 1197.49%
Operating Profit -$25.45K -$22.71K
YoY Change 12.07%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.620K -$25.45K -$22.71K
YoY Change 12.07% 1197.71%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.620K -$25.45K -$22.71K
YoY Change 12.07% 1197.49%
Net Earnings / Revenue -226.25% -1211.76%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.235M shares 3.235M shares 3.235M shares
Diluted Shares Outstanding 3.235M shares 3.235M shares

Balance Sheet

Concept 2023 Q1 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.810K $1.810K
YoY Change
Cash & Equivalents $1.810K
Short-Term Investments
Other Short-Term Assets $15.85K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.810K $1.810K $15.85K
YoY Change -88.58% -88.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.665K $3.670K $6.330K
YoY Change -42.13% -42.02% -29.67%
TOTAL ASSETS
Total Short-Term Assets $1.810K $1.810K $15.85K
Total Long-Term Assets $3.665K $3.670K $6.330K
Total Assets $5.475K $5.480K $22.18K
YoY Change -75.32% -75.29% 146.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.50K $21.50K $15.50K
YoY Change 38.71% 38.71% 63.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $8.980K $8.980K $6.240K
YoY Change 43.91% 494.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.48K $30.48K $21.74K
YoY Change 40.21% 40.2% 106.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $30.48K $30.48K $21.74K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $30.48K $30.48K $21.74K
YoY Change 40.2% 106.07%
SHAREHOLDERS EQUITY
Retained Earnings -$49.91K
YoY Change 104.04%
Common Stock $324.00
YoY Change 0.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.01K -$25.01K $440.00
YoY Change
Total Liabilities & Shareholders Equity $5.475K $5.480K $22.18K
YoY Change -75.32% -75.29% 146.44%

Cashflow Statement

Concept 2023 Q1 2023 2022
OPERATING ACTIVITIES
Net Income -$3.620K -$25.45K -$22.71K
YoY Change 12.07% 1197.49%
Depreciation, Depletion And Amortization $670.00 $2.670K $2.670K
YoY Change 0.0%
Cash From Operating Activities -$1.450K -$16.78K -$14.04K
YoY Change 19.52% 1023.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $24.70K
YoY Change -100.0% 12250.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.500K $2.741K $29.89K
YoY Change -90.83% 2290.96%
NET CHANGE
Cash From Operating Activities -1.450K -$16.78K -$14.04K
Cash From Investing Activities
Cash From Financing Activities 2.500K $2.741K $29.89K
Net Change In Cash 1.050K -$14.04K $15.85K
YoY Change -188.58%
FREE CASH FLOW
Cash From Operating Activities -$1.450K -$16.78K -$14.04K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3235000 shares
CY2022Q3 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023 dei Auditor Name
AuditorName
Victor Mokuolu, CPA PLLC
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023 dei Auditor Firm
AuditorFirmId
6771
CY2023Q1 us-gaap Cash
Cash
1810 usd
CY2022Q1 us-gaap Cash
Cash
15848 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1810 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
15848 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2667 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3665 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
6333 usd
CY2023Q1 us-gaap Assets
Assets
5475 usd
CY2022Q1 us-gaap Assets
Assets
22181 usd
CY2023Q1 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
8981 usd
CY2022Q1 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
6240 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21500 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15500 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30481 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21740 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
324 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
323 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24459 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25006 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5475 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22181 usd
CY2023 us-gaap Revenues
Revenues
2100 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27547 usd
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578603
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
24 Alexander Kazbegi Ave
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tbilisi
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0177
CY2023 dei City Area Code
CityAreaCode
702
CY2023 dei Local Phone Number
LocalPhoneNumber
605-46-36
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001852536
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Address Country
EntityAddressCountry
GE
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-255055
CY2023 dei Entity Registrant Name
EntityRegistrantName
INTORIO, CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22706 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
27547 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
22706 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-25447 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22706 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-22706 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1553 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24700 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-22706 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25006 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-22706 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2668 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2667 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16779 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14039 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24700 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2741 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5187 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2741 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29887 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14038 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15848 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15848 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1810 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15848 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24459 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zTzai23ynUt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86D_zRK5yv6hPK3e">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations during the reporting period, the Company made no material assumptions or estimates other than the assumption that the Company is a going concern and estimate with reference to amortization of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i/></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
CY2023Q1 us-gaap Cash
Cash
1810 usd
CY2022Q1 us-gaap Cash
Cash
15848 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2667 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2667 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares

Files In Submission

Name View Source Status
0001683168-23-002642-index-headers.html Edgar Link pending
0001683168-23-002642-index.html Edgar Link pending
0001683168-23-002642.txt Edgar Link pending
0001683168-23-002642-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_003.jpg Edgar Link pending
intorio_ex3101.htm Edgar Link pending
intorio_ex3102.htm Edgar Link pending
intorio_ex3201.htm Edgar Link pending
intorio_i10k-02282023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230228.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
intorio_i10k-02282023_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
none-20230228_cal.xml Edgar Link unprocessable
none-20230228_def.xml Edgar Link unprocessable
none-20230228_lab.xml Edgar Link unprocessable
none-20230228_pre.xml Edgar Link unprocessable